🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this observational study is to comprehensively profile six immu...
Status
Recruiting
Location
Radboud University Medical Center
Start Date
2025-07-29
Trial ID
NCT07021495
This study is being conducted to evaluate the efficacy and safety/tolerabil...
Status
Completed
Location
Multiple Locations
Start Date
2013-02-05
Trial ID
NCT01729754
The purpose of this study is to assess the efficacy, safety and tolerabilit...
Status
Completed
Location
Investigator Site 3
Start Date
2019-09-04
Trial ID
NCT04263610
This study is being conducted to evaluate the efficacy and safety/tolerabil...
Status
Withdrawn
Location
Multiple Locations
Start Date
2013-09
Trial ID
NCT01936688
Treatments Being Tested
A long term study to demonstrate the safety of Tildrakizumab in Subjects wi...
Status
Completed
Location
Site 25
Start Date
2018-07-11
Trial ID
NCT03552276
Treatments Being Tested
The main objective of this study is to investigate whether controlled dose ...
Status
Completed
Location
ULB Erasme
Start Date
2020-08-20
Trial ID
NCT04340076
Treatments Being Tested
This study is being conducted to evaluate the efficacy and safety/tolerabil...
Status
Completed
Location
Multiple Locations
Start Date
2012-12-06
Trial ID
NCT01722331
Treatments Being Tested
This is a response-driven study of tildrakuzumab for the treatment of moder...
Status
Completed
Location
Multiple Locations
Start Date
2010-10-25
Trial ID
NCT01225731
Treatments Being Tested